Cargando…
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285275/ https://www.ncbi.nlm.nih.gov/pubmed/25536336 http://dx.doi.org/10.3201/eid2101.140256 |
_version_ | 1782351561063661568 |
---|---|
author | Gamougam, Kadidja Daugla, Doumagoum M. Toralta, Jacques Ngadoua, Cyriaque Fermon, Florence Page, Anne-Laure Djingarey, Mamoudou H. Caugant, Dominique A. Manigart, Olivier Trotter, Caroline L. Stuart, James M. Greenwood, Brian M. |
author_facet | Gamougam, Kadidja Daugla, Doumagoum M. Toralta, Jacques Ngadoua, Cyriaque Fermon, Florence Page, Anne-Laure Djingarey, Mamoudou H. Caugant, Dominique A. Manigart, Olivier Trotter, Caroline L. Stuart, James M. Greenwood, Brian M. |
author_sort | Gamougam, Kadidja |
collection | PubMed |
description | In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted. |
format | Online Article Text |
id | pubmed-4285275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-42852752015-01-12 Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 Gamougam, Kadidja Daugla, Doumagoum M. Toralta, Jacques Ngadoua, Cyriaque Fermon, Florence Page, Anne-Laure Djingarey, Mamoudou H. Caugant, Dominique A. Manigart, Olivier Trotter, Caroline L. Stuart, James M. Greenwood, Brian M. Emerg Infect Dis Dispatch In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted. Centers for Disease Control and Prevention 2015-01 /pmc/articles/PMC4285275/ /pubmed/25536336 http://dx.doi.org/10.3201/eid2101.140256 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Dispatch Gamougam, Kadidja Daugla, Doumagoum M. Toralta, Jacques Ngadoua, Cyriaque Fermon, Florence Page, Anne-Laure Djingarey, Mamoudou H. Caugant, Dominique A. Manigart, Olivier Trotter, Caroline L. Stuart, James M. Greenwood, Brian M. Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title_full | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title_fullStr | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title_full_unstemmed | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title_short | Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 |
title_sort | continuing effectiveness of serogroup a meningococcal conjugate vaccine, chad, 2013 |
topic | Dispatch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285275/ https://www.ncbi.nlm.nih.gov/pubmed/25536336 http://dx.doi.org/10.3201/eid2101.140256 |
work_keys_str_mv | AT gamougamkadidja continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT daugladoumagoumm continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT toraltajacques continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT ngadouacyriaque continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT fermonflorence continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT pageannelaure continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT djingareymamoudouh continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT caugantdominiquea continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT manigartolivier continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT trottercarolinel continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT stuartjamesm continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 AT greenwoodbrianm continuingeffectivenessofserogroupameningococcalconjugatevaccinechad2013 |